Literature DB >> 23230186

Hello out there...is anybody listening?

Rosa Anna DeFilippis1, Thea D Tlsty.   

Abstract

Using a murine xenograft model system, Kuznetsov and colleagues show the existence of systemic interactions between a primary tumor and the growth of distal tumors in both homotypic and heterotypic tissues. Importantly, they show that the characteristics of the primary tumor govern the histologic features of the distal tumor through distinct pathways, thus providing novel opportunities for risk assessment, prognosis, prevention, and intervention. ©2012 AACR.

Entities:  

Mesh:

Year:  2012        PMID: 23230186      PMCID: PMC4326255          DOI: 10.1158/2159-8290.CD-12-0434

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  8 in total

1.  Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program.

Authors:  Matthew J Hayat; Nadia Howlader; Marsha E Reichman; Brenda K Edwards
Journal:  Oncologist       Date:  2007-01

Review 2.  The role of aspirin in cancer prevention.

Authors:  Michael J Thun; Eric J Jacobs; Carlo Patrono
Journal:  Nat Rev Clin Oncol       Date:  2012-04-03       Impact factor: 66.675

3.  Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice.

Authors:  Moshe Elkabets; Ann M Gifford; Christina Scheel; Bjorn Nilsson; Ferenc Reinhardt; Mark-Anthony Bray; Anne E Carpenter; Karin Jirström; Kristina Magnusson; Benjamin L Ebert; Fredrik Pontén; Robert A Weinberg; Sandra S McAllister
Journal:  J Clin Invest       Date:  2011-01-25       Impact factor: 14.808

4.  Identification of luminal breast cancers that establish a tumor-supportive macroenvironment defined by proangiogenic platelets and bone marrow-derived cells.

Authors:  Hanna S Kuznetsov; Timothy Marsh; Beth A Markens; Zafira Castaño; April Greene-Colozzi; Samantha A Hay; Victoria E Brown; Andrea L Richardson; Sabina Signoretti; Elisabeth M Battinelli; Sandra S McAllister
Journal:  Cancer Discov       Date:  2012-08-15       Impact factor: 39.397

5.  Metastatic behavior of breast cancer subtypes.

Authors:  Hagen Kennecke; Rinat Yerushalmi; Ryan Woods; Maggie Chon U Cheang; David Voduc; Caroline H Speers; Torsten O Nielsen; Karen Gelmon
Journal:  J Clin Oncol       Date:  2010-05-24       Impact factor: 44.544

6.  Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data.

Authors:  Jennifer Gnerlich; Donna B Jeffe; Anjali D Deshpande; Courtney Beers; Christina Zander; Julie A Margenthaler
Journal:  Ann Surg Oncol       Date:  2007-05-24       Impact factor: 5.344

7.  Systemic endocrine instigation of indolent tumor growth requires osteopontin.

Authors:  Sandra S McAllister; Ann M Gifford; Ashley L Greiner; Stephen P Kelleher; Matthew P Saelzler; Tan A Ince; Ferenc Reinhardt; Lyndsay N Harris; Bonnie L Hylander; Elizabeth A Repasky; Robert A Weinberg
Journal:  Cell       Date:  2008-06-13       Impact factor: 41.582

8.  Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials.

Authors:  Peter M Rothwell; Michelle Wilson; Jacqueline F Price; Jill F F Belch; Tom W Meade; Ziyah Mehta
Journal:  Lancet       Date:  2012-03-21       Impact factor: 79.321

  8 in total
  2 in total

1.  Interactions between the tumor and the blood systemic response of breast cancer patients.

Authors:  Vanessa Dumeaux; Bjørn Fjukstad; Hans E Fjosne; Jan-Ole Frantzen; Marit Muri Holmen; Enno Rodegerdts; Ellen Schlichting; Anne-Lise Børresen-Dale; Lars Ailo Bongo; Eiliv Lund; Michael Hallett
Journal:  PLoS Comput Biol       Date:  2017-09-28       Impact factor: 4.475

2.  Investigation of tumor-tumor interactions in a double human cervical carcinoma xenograft model in nude mice.

Authors:  Barbara Mertens; Tatiane Cristina de Araujo Nogueira; Dimitrios Topalis; Ruzena Stranska; Robert Snoeck; Graciela Andrei
Journal:  Oncotarget       Date:  2018-04-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.